New research has uncovered how genetic mutations hijack the production of blood cells in different periods of life. Scientists at the Wellcome Sanger Institute, the Cambridge Stem Cell Institute, EMBL's European Bioinformatics ...
Jun 1, 2022
0
79
New research has uncovered how genetic changes that accumulate slowly in blood stem cells throughout life are likely to be responsible for the dramatic change in blood production after the age of 70.
Jun 1, 2022
0
202
In a first-of-its-kind experiment, researchers have identified links between 127 genes and immune diseases, providing newfound insights into the sequence and timing of gene activity during the activation of T cells, a key ...
May 26, 2022
0
54
The Human Cell Atlas goal of mapping every cell type in the human body to transform our knowledge of biology, infection and disease is a milestone step closer with four studies published in Science today.
May 12, 2022
0
85
Some rare cases of higher genetic mutation rates in children, known as hypermutation, could be linked to the father receiving certain chemotherapy treatments, new research has found.
May 11, 2022
0
47
Researchers from the Wellcome Sanger Institute, the Hudson Institute of Medical Research, Australia, the University of Cambridge and collaborators, have discovered and named two new strains of bacteria in the microbiome of ...
Apr 14, 2022
0
114
Scientists have long queried the causes of immune disorders in only one of two identical twins with identical genes. New research from the Wellcome Sanger Institute, the Josep Carreras Leukemia Research Institute in Spain ...
Apr 1, 2022
0
155
New research suggests that genetic variants that damage the genome are associated with reduced reproductive success and an increased likelihood of not having children.
Mar 24, 2022
0
28
New research has begun to unravel the mystery of why a particular form of leukemia in infants has defied efforts to improve outcomes, despite significant improvements in treating older children. Scientists from the Wellcome ...
Mar 14, 2022
0
92
Sanger researchers have created the world's largest novel resource using systematic drug testing and genetics analyses to show new potential drug combinations for breast, colon, and pancreatic cancer.
Feb 24, 2022
0
119
